Search hospitals > Florida > Miami
University of Miami Miller School of Medicine
Claim this profileMiami, Florida 33136
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Antiretroviral Therapy
Conducts research for Systemic Sclerosis
Conducts research for Thyroid Fibrosis
Conducts research for HIV/AIDS
369 reported clinical trials
24 medical researchers
Summary
University of Miami Miller School of Medicine is a medical facility located in Miami, Florida. This center is recognized for care of Human Immunodeficiency Virus Infection, Antiretroviral Therapy, Systemic Sclerosis, Thyroid Fibrosis, HIV/AIDS and other specialties. University of Miami Miller School of Medicine is involved with conducting 369 clinical trials across 493 conditions. There are 24 research doctors associated with this hospital, such as Sabine s Coppieters, MD, Cynthia Levy, MD, Marilyn Huang, and Craig Moskowitz, MD.Top PIs
Sabine s Coppieters, MDInvestigator site 2 - US00100873 years of reported clinical research
Studies Myasthenia Gravis
Studies Muscle Weakness
25 reported clinical trials
13 drugs studied
Cynthia Levy, MDUniversity of Miami Miller School of Medicine2 years of reported clinical research
Studies Infective Cholangitis
Studies Primary Biliary Cirrhosis
12 reported clinical trials
12 drugs studied
Marilyn HuangUniversity of Miami3 years of reported clinical research
Studies Ovarian Cancer
Studies Endometrial Cancer
13 reported clinical trials
22 drugs studied
Craig Moskowitz, MDUniversity of Miami1 year of reported clinical research
Expert in Lymphoma
Studies Hodgkin's Lymphoma
12 reported clinical trials
23 drugs studied
Clinical Trials running at University of Miami Miller School of Medicine
Lymphoma
Traumatic Brain Injury
Multiple Sclerosis
Stroke
Lupus
Acute Myeloid Leukemia
Cardiomyopathy
Systemic Sclerosis
Tourette Syndrome
Hodgkin's Lymphoma
Brentuximab Vedotin
for Hodgkin Lymphoma
RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led and sponsored by University College London (UCL) and conducted in Europe and Australia/New Zealand. Trial 2 will be led by the Canadian Cancer Trials Group (CCTG) and conducted in North America, with CCTG the regulatory sponsor in Canada, and University of Miami the regulatory sponsor and IND holder in the US. Datasets from Trial 1 and Trial 2 will be combined to achieve the total sample size. Data analysis will be performed by UCL and therefore UCL is responsible for the clinicaltrials.gov entry. Eligible patients will be randomised to receive either ABVD or A2VD chemotherapy. An interim PET-CT scan will be performed after 2 cycles of treatment, which will be used to adapt subsequent treatment. Patients will receive a total of 3-4 cycles of chemotherapy and may also receive involved site radiotherapy as consolidation. Patients will be followed up for a minimum of 5 years after treatment.
Recruiting2 awards Phase 313 criteria
Daratumumab + Chemotherapy
for Lymphoma
This trial studies how well daratumumab combined with chemotherapy works in treating patients with a specific type of lymphoma. The treatment targets cancer cells with a protein called CD38, helping the immune system attack them and stopping their growth. Daratumumab is a CD38 monoclonal antibody approved for treating relapsed/refractory and newly diagnosed multiple myeloma.
Recruiting1 award Phase < 110 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Miami Miller School of Medicine?
University of Miami Miller School of Medicine is a medical facility located in Miami, Florida. This center is recognized for care of Human Immunodeficiency Virus Infection, Antiretroviral Therapy, Systemic Sclerosis, Thyroid Fibrosis, HIV/AIDS and other specialties. University of Miami Miller School of Medicine is involved with conducting 369 clinical trials across 493 conditions. There are 24 research doctors associated with this hospital, such as Sabine s Coppieters, MD, Cynthia Levy, MD, Marilyn Huang, and Craig Moskowitz, MD.
Where is University of Miami Miller School of Medicine located?
**University of Miami Miller School of Medicine Hospital**
- **Address:** 1150 NW 14th St, Miami, FL 33136.
- **Directions:** Exit I-95 onto SR 836 West, then stay right to exit onto NW 12th Avenue. Continue north to enter the medical center complex at NW 16th Street.
Who should I call to ask about financial aid or insurance network?
**University of Miami Miller School of Medicine Hospital Contact Information:**
- **Financial Assistance:**
- Phone: 305-689-7079
- Email: charityrequest@miami.edu
- **Insurance Department Inquiries:**
- Phone: 305-243-2900
- Email: UHIBilling@miami.edu
What insurance does University of Miami Miller School of Medicine accept?
The University of Miami Miller School of Medicine offers a range of insurance plans. For students, Aetna Student Health is the primary provider, with an option to waive this requirement if they have an equivalent policy. Employees can choose from three medical plans: Aetna Select 1, Aetna Select 2, and the HRA.
What awards or recognition has University of Miami Miller School of Medicine received?
The University of Miami Miller School of Medicine hospital, located in Miami, Florida, is the leading institution in Florida for research funding from the National Institutes of Health. It is globally recognized for its clinical research, which contributes to innovative patient care and attracts top medical talent.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.